Education
About Us
Working with TipRanks
Follow Us
TMFM - ETF AI Analysis
Top Page
Motley Fool Mid-Cap Growth ETF (TMFM)
Rating:69Neutral
Price Target:―
Positive Factors
Leading Holdings With Solid Momentum
Several of the largest positions, such as QXO Inc, StoneX Group, and Penumbra, have shown strong year-to-date performance, helping support the fund’s overall results.
Diversified Across Key Growth Sectors
The ETF spreads its investments across technology, health care, industrials, financials, and consumer-related sectors, which helps reduce reliance on any single industry.
Focused Mid-Cap Growth Exposure
By targeting mid-sized growth companies, the fund offers access to businesses that may have more room to expand than many large, mature firms.
Negative Factors
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of staying with investors.
Mixed Performance Among Top Holdings
Several major positions, including Broadridge Financial Solutions, Healthequity, Toast, and GooseHead Insurance, have shown weak year-to-date performance, which can drag on the fund’s returns.
Heavy Concentration in U.S. Market
With nearly all assets invested in U.S. companies, the ETF offers little geographic diversification and is highly sensitive to movements in the U.S. market.
TMFM vs. SPDR S&P 500 ETF (SPY)
AUM142.36M
RegionNorth America
Expense Ratio0.85%
Beta0.91
IssuerMotley Fool
Inception DateDec 10, 2021
Dividend Yield0.06%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume8,994
30 Day Avg. Volume12,855
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
29.94Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering30
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TMFM Summary
The Motley Fool Mid-Cap Growth ETF (TMFM) focuses on medium-sized U.S. companies that are expected to grow faster than the overall market, rather than tracking a traditional index. It spreads money across areas like technology, health care, and industrials, with holdings such as Dexcom and Toast. Someone might invest in TMFM to seek long-term growth and diversify beyond the biggest, most well-known large-cap stocks, while still avoiding the smallest, riskiest companies. A key risk is that growth-focused mid-cap stocks can be quite volatile, so the ETF’s value can rise and fall sharply with market conditions.
How much will it cost me?The Motley Fool Mid-Cap Growth ETF (TMFM) has an expense ratio of 0.85%, meaning you’ll pay $8.50 per year for every $1,000 invested. This is higher than average because it is actively managed, relying on expert stock-picking to target mid-cap growth companies with strong potential.
What would affect this ETF?The TMFM ETF, with its focus on U.S. mid-cap growth companies, could benefit from advancements in technology and innovation, particularly as its largest sector exposure is technology. Positive economic conditions and increased consumer spending may also support growth in sectors like industrials and financials. However, rising interest rates or regulatory changes could negatively impact growth-focused companies, especially in sectors like real estate and financials, which are sensitive to such factors.
TMFM Top 10 Holdings
TMFM is leaning hard into U.S. mid-cap growth, with a clear tilt toward tech, health care, and financial services. Recent strength from QXO and Penumbra has been doing the heavy lifting, giving the fund a nice boost as these names keep climbing. Dexcom is also pulling its weight with steady, rising momentum. On the flip side, Broadridge, Toast, and HealthEquity have been losing steam, acting more like brakes than an engine. Overall, the fund is concentrated in a handful of mid-cap innovators, mostly in the U.S. growth sweet spot.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| QXO Inc | 5.65% | $8.13M | $16.69B | 73.43% | 66 Neutral | |
| StoneX Group | 5.17% | $7.44M | $5.68B | 47.89% | 58 Neutral | |
| Broadridge Financial Solutions | 4.75% | $6.83M | $24.09B | -13.02% | 78 Outperform | |
| GXO Logistics | 4.70% | $6.77M | $6.63B | 24.64% | 68 Neutral | |
| Dexcom | 4.62% | $6.65M | $28.73B | -15.12% | 79 Outperform | |
| Toast Inc | 4.34% | $6.24M | $19.10B | -20.43% | 73 Outperform | |
| Healthequity | 4.32% | $6.22M | $7.09B | -23.85% | 76 Outperform | |
| Brown & Brown | 4.23% | $6.09M | $25.31B | -28.16% | 76 Outperform | |
| Penumbra | 4.16% | $5.99M | $14.10B | 33.11% | 78 Outperform | |
| GooseHead Insurance | 3.86% | $5.55M | $2.34B | -41.08% | 59 Neutral |
TMFM Technical Analysis
Negative
―
Price Trends
23.68
Negative
24.12
Negative
24.99
Negative
Market Momentum
-0.12
Positive
34.55
Neutral
17.20
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TMFM, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 23.81, equal to the 50-day MA of 23.68, and equal to the 200-day MA of 24.99, indicating a bearish trend. The MACD of -0.12 indicates Positive momentum. The RSI at 34.55 is Neutral, neither overbought nor oversold. The STOCH value of 17.20 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TMFM.
TMFM Peer Comparison
Comparison Results
Performance Comparison
TMFM
Motley Fool Mid-Cap Growth ETF
22.82
-4.62
-16.84%
AVMV
Avantis U.S. Mid Cap Value ETF
―
―
―
TMVE
Thrivent Mid Cap Value ETF
―
―
―
AVMC
Avantis U.S. Mid Cap Equity ETF
―
―
―
FRTY
Alger Mid Cap 40 ETF
―
―
―
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents